Objective: Although many observational studies have shown that there was an 25 inverse association between birth weight and chronic kidney disease (CKD) in adults, 26 whether such association is causal remains largely unclear. 27
Introduction

49
Chronic kidney disease (CKD) is a common complex disease which influences both 50 children and adult populations (Levey et al., 2015; Webster et al., 2017) . At the initial 51 disease stage, CKD is asymptomatic and may be ignored by sufferers. It is common 52 that the diagnosis of CKD is made when disease symptoms already become severe. 53
Moreover, a series of severe complications (e.g. renal failure, hypertension, cancer, 54 infection and coronary heart disease) can occur with the decreased renal function of 55 CKD patients (Di Lullo et al., 2015; Webster et al., 2017) . Additionally, due to the 56 decreased GFR during the disease progression as well as possible complications, the 57 life quality of CKD patients is significantly lower than that of the general population. 58
It is estimated that the global prevalence of CKD ranges between 11% and 13%, and 59 that CKD can account for 1.5% death worldwide, making it among the leading death 60 risk and a global public health issue (Hill et al., 2016) . World Health Organization 61 (WHO) predicts that the deaths attributable to kidney-related diseases will increase by 62 31% (from ~871,000 in 2015 to ~1,143,000 in 2030) in the next decade due to the 63 growing disease rate and aging population (Organization, 2018) . Therefore, 64
identifying the risk factors of CKD can promote our understanding of the 65 pathogenesis of this disease, having the potential to ultimately lead to better 66 prevention and treatment for CKD, and is also important in terms of the public health 67 perspective (Luyckx and Brenner, 2015; Luyckx et al., 2017; Webster et al., 2017) . illustrated that low birth weight was associated with an increased risk of CKD; owing 91 to the heterogeneity in disease onset age, geographic diversity and ethnic differences, 92 a few of other studies did not support the existence of the inverse relationship between 93 birth weight and CKD (Fagerudd et al., 2006; Haysom et al., 2007) , and sometimes 94 even reported contradictory findings (Vasarhelyi et al., 2000) . For example, no early 95 glomerular and tubular damage was observed in young men with low birth weight 96 compared with those with normal birth weight (Vasarhelyi et al., 2000) . 97
The inconsistent observations regarding the relationship between birth weight and 98 CKD may be also partly due to uncontrolled/unknown confounders which are 99 commonly encountered in observational studies. Indeed, there are studies which 100 suggested that the impaired kidney function in adulthood may be a consequence of 101 high blood pressure (Vasarhelyi et al., 2000) . Thus, it remains a concern when 102 interpreting the observed relationship between birth weight and CKD as a causal 103 association. A cohort longitudinal study may alleviate such concern and offer an 104 important insight into the causal interpretation. However, longitudinal studies require 105 large scale subjects and need very long-term follow-ups before CKD clinical 106 presentation. Traditionally, randomized controlled trials (RCT) studies are the gold 107 standard for inferring the causal effect of exposure on outcome. However, determining 108 the causal relationship between birth weight and CKD by RCT is infeasible. It seems 109 that the validation of the fetal origins hypothesis for CKD is extremely difficult in a 110 traditional manner. 111
5/27
In observational studies Mendelian randomization (MR) can help clarify the causal 112 relationship between an exposure of interest and an outcome, and provide an efficient 113 way for causal inference. Briefly, MR is a special instrumental variable method that 114 employs genetic variants (e.g. single nucleotide polymorphisms (SNPs)) as 115 instruments for an exposure (i.e. birth weight) and evaluates its causal effect on the 116 outcome (i.e. CKD). In the past ten years the great success of genome-wide 117 association studies (GWASs) makes it feasible to select suitable SNPs as effective 118 instruments for causal inference in MR. In fact, MR has recently become a 119 considerably popular approach of inferring causal relationship in observational 120 Motivated by those previous observations above, our main goal in this study was two 125 aspects. First, to illuminate whether there exists an association between birth weight 126 and CKD, we employed the systematic review and meta-analysis to provide a pooled 127 conclusion. The result showed that birth weight is inversely associated with CKD, 
Data extraction and Statistical analysis in meta-analysis 152
For each article that was incorporated into our meta-analysis, two investigators (XH 153 and PZ) independently carried out data extraction and quality assessment. From each 154 article we extracted the information about study setting and design, population and 155 sample size for case and control, effect size (e.g. odds ratio (OR), relative ratio (RR) 156 or hazard ratio (HR)) as well as covariates that were adjusted for in the original 157 analysis. The effect size heterogeneity among studies was tested by the Cochran's Q 158 statistic (Thompson and Sharp, 1999) . We estimated the combined effect of birth 159 weight on CKD using a weighted meta-analysis method and evaluated the published 160 bias by the Egger method and funnel plot (Egger et al., 1997). We also performed a 161 leave-one-out (LOO) analysis to assess the influence of a single study. 162 7/27
MR analysis 163
GWAS data sources for birth weight and CKD 164
In our meta-analysis above we found that there exists a robust inverse association 165 between birth weight and CKD (see below for more details). To examine whether this 166 identified association is causal, we further performed a MR analysis based on large 167 scale GWAS genetic data of birth weight and CKD. To achieve this, we first yielded 168 the genetic data of birth weight from the Early Growth Genetics (EGG) consortium 169 (http://egg-consortium.org) (Horikoshi et al., 2016) . In this study, birth weight was 170 measured as a continuous variable and an additive linear regression was adopted for 171 each SNP to detect its association with birth weight while controlling for available 172 covariates (e.g. gestational age). After quality control of SNP genotypes and Table S1 . Since participants had 187 given informed consent for data sharing as described in each of the original GWASs 188 and only summary association results were employed; therefore, ethical review was 189 not needed for our study. 190
Estimation of causal effect of birth weight on CKD and sensitivity analyses 191
We then employed MR approaches to determine the causal relationship between birth 192 weight and CKD. First, to ensure the validity of MR we carefully selected a set of 
Combined effect of birth weight on CKD in systematic review and meta-analysis 215
A total of 20 studies satisfied the inclusion criteria and were finally incorporated into 216 our systematic review and meta-analysis ( Fig. S1 ). Most of the included studies were 217 carried out on European individuals. The extracted information of those studies is 218 shown in Table 1 . All the studies reported the risk of CKD for low birth weight 219 compared with normal birth weight, and nine additionally reported the risk of CKD 220 for high birth weight compared with normal birth weight. Note that the definition of 221 low/high birth weight was slightly different across studies (see Table 1 for more 222 details). Among those, 16 studies showed that low birth weight can increase the risk 223 of CKD in later life. Additionally, five out of nine studies demonstrated that high birth 224
weight can also raise the risk of CKD. Those results suggested that there may exist a 225 U-shaped relationship between birth weight and CKD. We thus performed 226 meta-analysis for the association between low or high birth weight with CKD 227 separately ( Fig. 1) . 228
Owing to the presence of heterogeneous effect size of birth weight on CKD in those 229 studies (the p values of the Q statistic are less than 0.05 for both low and high birth 230 weight; Fig. 1 ), the results of the random-effects meta-analysis are displayed here. 231
Specifically, we found that the risk of CKD for adult individuals with low birth weight 232 is 76% (OR=1.76, 95% CI 1.37~2.26, p=1.27E-5) higher compared with those with 233 normal birth weight ( Fig. 1A) , implying that lower birth weight leads to more 234 vulnerable to CKD. This inverse relationship also holds in the sub-group 235 meta-analyses in terms of gender or the type of study design ( Fig. S2-S3 ). However, 236 no significant association is observed between high birth weight and CKD (OR=1.05, 237 95% CI 0.81~1.37, p=0.713; Fig. 1B ). These results are robust according to the LOO 238 analyses which show that no single study can substantially dominate the final 239 combined estimates (Table S3 -S4). Additionally, the Egger test (p=0.170 for low birth 240 weight and p=0.982 for high birth weight), together with the funnel plot ( Fig. S2) , 241 demonstrates that the publication bias is less likely to influence the combined 242 estimates in our meta-analysis. In summary, based on the results of meta-analysis 243 above, we can conclude that an inverse association exists between birth weight and 244 CKD, but no evidence is present for the observed U-shaped relationship. 245
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Estimated causal effect of birth weight on CKD 246
In our MR analysis, a total of 26 independent index SNPs served as instrument 247 variables for birth weight. They jointly explain a total of 0.91% of phenotypic 248 variance for birth weight. The F statistics of those instruments range from 27.6 to 249 175.6 (with an average of 49.26), indicating that the weak instrument bias does not 250 likely occur in our analysis. Little evidence of causal effect heterogeneity across 251 instruments is observed (Q=23.08 and p=0.573); therefore, we employed the 252 fixed-effects IVW MR method to estimate the causal effect and found that there exists 253 a negative but non-significant casual association between birth weight and CKD. 254
More specifically, the OR per one SD increase of birth weight on CKD is 0.91 (95% 255 CI 0.72~1.14, p=0.396), consistent with those produced by the weighted median 256 method (OR=0.86, 95% CI 0.62~1.18, p=0.346) and by the maximum likelihood 257 approach (OR=0.91, 95% CI 0.72~1.14, p=0.414). The similarly null causal 258 association was also observed if we employ other sets of instrumental variables for 259 birth weight (Supplementary File). In addition, we also did not discover a significant 260 casual association between birth weight and other kidney-related traits (Fig. S5) . 261
We next examined whether there are potential instrument outliers and whether these 262 outliers have a substantial influence on the estimate of causal effect. To do so, we 263 created a scatter plot by drawing the effect sizes of SNPs of birth weight against those 264
SNPs of CKD for all the used instruments ( Fig. 2A) . It is shown that no instrumental 265 variables can be considered potential outliers. The result of MR-PRESSO also 266 displays that there do not exist instrument outliers at the significance level of 0.05. 267
Consistently, in terms of the result of the LOO analysis, no single instrument can have 268 a substantial influence on the estimation of causal effect (Table S5) Nevertheless, we note that the estimated causal effects between birth weight and CKD 323 were consistent in the direction and magnitude through multiple MR methods (e.g. 324 IVW, weighted median method and maximum likelihood estimation). There are 325 several explanations for the failure of detecting a causal association between birth 326 weight and CKD given the observation that low birth weight is robustly related to the 327 increased risk of CKD in our meta-analysis. First, this inverse relationship in 328 observational studies may be driven by shared genetic components between birth 329 weight and CKD. To check this, we applied the linkage disequilibrium score 330 regression (LDSC) (Bulik-Sullivan et al., 2015) to quantify the genetic covariance 331 between birth weight and CKD. LDSC is a novel statistical genetic method for 332 quantifying genetic correlation for two traits based on the genome-wide pleiotropy 333 (note that our MR analysis has removed the influence of pleiotropic effects). With 334 LDSC, we found a pronounced but nonsignificant genetic correlation between birth 335 weight and CKD (R g =-0.234, se=0.081, p=0.771; see Table S6 for more information), 336 suggesting the common polygenic risk shared by low birth weight and CKD. More 337 specifically, this means that some SNPs that are associated with low birth weight also 338 related to the risk of CKD. Second, the failure of detecting non-zero causal effect of 339 birth weight on CKD may be partly due to a lack of adequate statistical power. To 340 examine this, we performed the statistical power calculation to discover an OR of 0.80 341 13/27 or 0.90 in the risk of CKD per unit change of birth weight following the approach 342 shown in (Brion et al., 2013) . Note that, these assumed ORs approximately equal to 343 the estimated effect size of birth weight on CKD in our study. The results imply that 344 we have a small to moderate power to detect the causal association between birth 345 weight and CKD due to the small number of CKD cases (Fig. 3) . For example, with 346 the current sample size of CKD in our study (i.e. assume the sample size of adult 347 CKD is 117,000 and the proportion of cases is 10.6%), the estimated statistical power 348 is 17% or 25% to detect an OR of 0.80 or 0.90, respectively. Third, we cannot rule out 349 the possibility that there exist some unknown pathways which mediate the influence Therefore, when combining these heterogeneous CKDs together in analysis, a large 366 degree of deviation may be introduced in our analysis. Second, as mentioned above, 367 we have only a limited statistical power in our MR analysis due to the small sample 368 size of cases in the CKD GWAS. Third, like many previous MR studies we 369 hypothesized that there is a linear relationship between birth weight and CKD in our 370 analysis. Linearity may be unreasonable in practice since previous epidemiological 371 studies have found that high birth weight also increases the risk of CKD, implying a 372 U-type relationship between birth weight and CKD. Therefore, we cannot completely 373 remove the nonlinear influence of birth weight on CKD. Fourth, our MR relies on 374 14/27 summary statistics rather than individual-level data sets, thus we cannot analyze the 375 relationship between very low/high birth weight and CKD due to lack of relevant data 376 information, and we are also unable to conduct stratified analyses (e.g. in terms of 377 gender; see Table 1 ) in our MR study. 378
In conclusion, our study identifies an inverse association between birth weight and 379 CKD in observational studies, while it is not supportive of the causal role of birth 380 weight on the risk of CKD based on our MR analysis. 381
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